Key takeaways:
GLP-1, or glucagon-like peptide-1, is a natural hormone produced in the human body. Its primary purpose is to help the body manage blood sugar levels after a person eats a meal. It is released from specialized cells in the intestine in response to food intake.
Medical science has developed medications that act like the body's natural GLP-1. These medications are used to treat conditions such as type 2 diabetes and to assist with weight management. They have become significant tools in treating these chronic health issues.
GLP-1 medications started as only a diabetes treatment, and became a weight management tool after the observation of their effects on appetite and weight. Researchers noticed that patients with type 2 diabetes who were taking these medications not only experienced improved blood sugar control but also often lost a significant amount of weight.
This discovery led to further research and development, resulting in some of these medications being explicitly approved for weight management.
GLP-1 medications are designed to mimic the natural hormone. When these medications are introduced, they activate receptors in the body that respond to GLP-1. This activation leads to several key effects:
GLP-1 medications can have side effects, which a patient may experience during treatment. The most frequently reported side effects are related to the digestive system.
Digestive side effects may include:
Less common side effects can include headaches, fatigue, or dizziness. While many side effects are temporary and manageable, some may require dose adjustments or discontinuation of the medication. The severity and type of side effects can vary from person to person and depend on the specific medication.
Healthcare professionals, such as nurses, play a key role in monitoring patients using GLP-1 medications. Their focus is on ensuring patient safety, managing any side effects that may occur, and providing necessary support and education.
Nurses and other healthcare providers should focus on the following:
Effective and open communication between the patient and the healthcare provider is essential for a successful treatment plan. Patients should feel comfortable reporting any and all symptoms, as this information is vital for the medical team to provide the best possible care.
The popularity and high demand for GLP-1 medications have led to the emergence of a market for unapproved and counterfeit versions. These products pose significant health and safety risks. It is crucial for patients and the public to understand the difference between Food and Drug Administration (FDA)-approved medications and these unapproved alternatives.
Unapproved GLP-1 products can fall into several categories, including:
Unapproved products have not been subject to the rigorous clinical trials and quality control standards required for FDA approval. As a result, their safety and effectiveness are not guaranteed. They may not work as intended or could cause unexpected and severe side effects.
Before starting any GLP-1 medication, a patient should be carefully evaluated by a medical professional who is licensed to prescribe it. This includes reviewing the full medical history to identify any conditions that may prevent the use of the medication.
Certain conditions, such as a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), are contraindications for these medications.
The healthcare provider will also assess the patient's current health status to determine if the benefits of the medication outweigh the potential risks.
GLP-1 medications are a tool that must be used under the guidance of a qualified healthcare provider.
They are not a quick fix but a part of a broader treatment plan that often includes dietary changes, increased physical activity, and regular monitoring. Patients should never share their medication with others or use it without a prescription.
GLP-1 medications are designed to work like a natural hormone to help manage conditions like type 2 diabetes and obesity. Like all medications, they have potential side effects, primarily related to the digestive system, that must be carefully managed.
The role of healthcare professionals is critical in ensuring the safe and effective use of these treatments through patient education, consistent monitoring, and open communication.
About the Author:
Breann Kakacek, BSN, RN, has been a registered nurse since 2015 and a CNA prior to that for two years while going through the nursing program. Most of her nursing years included working in the medical ICU, cardiovascular ICU, and the OR as a circulating nurse. She has always had a passion for writing and enjoys using her nursing knowledge to create unique online content. You can learn more about her writing career and services at ghostnursewriter.com
Breann is an independent contributor to CEUfast's Nursing Blog Program. Please note that the views, thoughts, and opinions expressed in this blog post are solely of the independent contributor and do not necessarily represent those of CEUfast. This blog post is not medical advice. Always consult with your personal healthcare provider for any health-related questions or concerns.
If you want to learn more about CEUfast's Nursing Blog Program or would like to submit a blog post for consideration, please visit https://ceufast.com/blog/submissions.